Literature DB >> 26933845

Pharmaceutical Policy Reform--Balancing Affordability with Incentives for Innovation.

Rena M Conti1, Meredith B Rosenthal1.   

Abstract

Mesh：

Year:  2016        PMID： 26933845     DOI： 10.1056/NEJMp1515068

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Pricing of innovative drugs: correlation between incremental cost and survival gain in four countries.

Authors:  Daniele Mengato; Andrea Messori
Journal:  Ther Adv Med Oncol       Date:  2016-05-16       Impact factor: 8.168

2.  Covering the Cost of the Cure: From Hepatitis C to Cancer, New Therapies Are Straining a System Plagued by Inefficiency.

Authors:  Peter Sonnenreich; Linda Geisler
Journal:  P T       Date:  2016-09

3.  Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries.

Authors:  Ya-Chen Tina Shih; Ying Xu; Lei Liu; Fabrice Smieliauskas
Journal:  J Clin Oncol       Date:  2017-05-04       Impact factor: 44.544

4.  Access to High Cost Cancer Medicines Through the Lens of an Australian Senate Inquiry-Defining the "Goods" at Stake.

Authors:  Narcyz Ghinea; Miles Little; Wendy Lipworth
Journal:  J Bioeth Inq       Date:  2017-07-18       Impact factor: 1.352

Review 5.  Approaches to manage 'affordability' of high budget impact medicines in key EU countries.

Authors:  Mathias Flume; Marc Bardou; Stefano Capri; Oriol Sola-Morales; David Cunningham; Lars-Ake Levin; Maarten J Postma; Nicolas Touchot
Journal:  J Mark Access Health Policy       Date:  2018-06-08

Review 6.  A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors.

Authors:  Vivek Verma; Tanja Sprave; Waqar Haque; Charles B Simone; Joe Y Chang; James W Welsh; Charles R Thomas
Journal:  J Immunother Cancer       Date:  2018-11-23       Impact factor: 13.751

7.  Patients' Perception of Morocco's Medicine Pricing Reform and Determinants of Their Access to Health Care and Medicine.

Authors:  Amine Cheikh; Meryem Moutahir; Ismail Bennani; Houda Attjioui; Wadie Zerhouni; Mustapha Bouatia
Journal:  Biomed Res Int       Date:  2021-10-04       Impact factor: 3.411

8.  Upstream solutions for price-gouging on critical generic medicines.

Authors:  Adam R Houston; Reed F Beall; Amir Attaran
Journal:  J Pharm Policy Pract       Date:  2016-05-02

9.  Branded prescription drug spending: a framework to evaluate policy options.

Authors:  Jeromie Ballreich; G Caleb Alexander; Mariana Socal; Taruja Karmarkar; Gerard Anderson
Journal:  J Pharm Policy Pract       Date:  2017-10-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.